Pulmonary
Other Pulmonary Conditions
Pulmonary

Other Pulmonary Conditions

CO poisoning, ARDS, pulmonary contusion, IPF, PE, cor pulmonale.

Select any text to highlight it or make a flashcard.

◆CO poisoning

  • •Headache + confusion + enclosed space + NORMAL SpO₂ (CO binds Hb >200x more than O₂)
  • •Check carboxyhemoglobin level
  • •100% O₂ via non-rebreather
  • •Hyperbaric O₂ if pregnancy, neuro symptoms, COHb >25%

◆ARDS

  • •Acute bilateral infiltrates + refractory hypoxemia + PaO₂/FiO₂ ≤300 + normal heart size
  • •Low tidal volume ventilation (~6 mL/kg PBW) — only strategy proven to improve mortality
  • •PEEP to prevent alveolar collapse
  • •Target SpO₂ 88–95% (avoid O₂ toxicity)
  • •Permissive hypercapnia tolerated
  • •Treat underlying (sepsis, etc.)

◆Ventilator adjustments

  • •Oxygenation problem (↓PaO₂): ↑FiO₂ or ↑PEEP
  • •Ventilation problem (↑PaCO₂): ↑RR (do NOT increase TV in ARDS)
  • •ARDS rule: keep VT ~6 mL/kg

◆Other lung topics

  • •Pulmonary contusion: blunt trauma + patchy alveolar opacities + hypoxia → supportive
  • •Atelectasis: post-op fever + hypoxemia without hypercapnia in first 48 hr → incentive spirometry
  • •TRALI: <6 hr post-transfusion + noncardiogenic edema → supportive (no diuretics); normal JVP
  • •TACO: <6 hr post-transfusion + cardiogenic edema + ↑JVP/HTN → diuretics
  • •Decompression sickness: after rapid scuba ascent + neuro/pulm sx → hyperbaric O₂
  • •PE: cancer + recent surgery + sudden dyspnea → CTPA
  • •Idiopathic pulmonary fibrosis: progressive dyspnea + dry cough + basilar peripheral honeycombing → pirfenidone, nintedanib
  • •Sarcoidosis: observe if asymptomatic; steroids if symptomatic or organ-threatening
  • •Asbestosis: pleural plaques + lower-lobe fibrosis → highest risk = bronchogenic CA (not mesothelioma)
  • •Pancoast tumor: smoker + apical mass + shoulder pain + Horner syndrome

◆Lung cancer screening

  • •Low-dose CT annually (NOT CXR or sputum cytology)
  • •Age 50–80, ≥20 pack-years, current smoker or quit within 15 years (USPSTF 2021)
  • •Stop when age >80, ≥15 years since quitting, or life-expectancy-limiting illness
  • •Lung-RADS classification for nodule follow-up

◆Amiodarone toxicity

  • •Lungs (pulmonary fibrosis/pneumonitis)
  • •Thyroid (hyper- or hypothyroidism)
  • •Liver
  • •Skin (blue-gray)
  • •Optic neuritis, corneal microdeposits
  • •Always get TFTs, PFTs, LFTs before starting
Quick check

5-question quiz on this note

Test yourself before moving on. ~1 min.

Done reading?
Track your progress by marking this complete.
Next in Pulmonary